摘要
目的研究CHL1在脑胶质细胞瘤中表达的临床意义。方法采用RT-PCR和Western blot检测脑胶质细胞瘤原发组织和瘤旁组织中CHL1的表达,分析其与临床病理因素关系。结果 CHL1在脑胶质细胞瘤原发瘤组织中的表达低于相应的瘤旁组织。结论为研究脑胶质细胞瘤发生和进展提供了策略。
Objective To evaluate the diagnostic value of CHL1 in glioma patients.Methods RT-PCR and Western blot were used to examine the expression of CHL1 in samps, including 100 normal tissues and 30 primary tumors.Results CHL1 was low-regulated in glioma and related to LN.Conclusion Our results may provide a strategy for blocking glioma and progression.
出处
《中国现代药物应用》
2014年第8期3-5,共3页
Chinese Journal of Modern Drug Application